2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Long COVID: new trials by email Literature Review of Long COVID trials Research Report on Long COVID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lithium Long COVID Dose-finding Study Lithium - Long COVID | Phase 1 | Completed | State University of New York at Buffalo | 5 | 2023-10-12 | 2024-10-22 |
| Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID stellate ganglion block with 0.5% bupivacaine - Post Acute COVID-19 Syndrome, Long COVID | Phase 1 | Completed | Jonathann Kuo, MD | 20 | 2023-01-03 | 2025-03-13 |
Post-Acute COVID-19 Syndrome (2) · Autonomic Nervous System Diseases (1) · COVID-19 (1) · Dysautonomia like disorder (1) · Shy-Drager Syndrome (1)
Chronic Disease (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Disease Attributes (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Pneumonia (2) · Pneumonia, Viral (2) · Post-Infectious Disorders (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2)
Bupivacaine (1) · Lithium (1)
Jonathann Kuo, MD (1) · State University of New York at Buffalo (1)
United States (2)